George D. Yancopoulos
2020
Compensation breakdown
Non-Equity Incentive Plan | $3,004,391 |
---|---|
Salary | $1,258,096 |
Stock Awards | $130,000,032 |
Other | $120,800 |
Total | $134,383,319 |
Yancopoulos received $130M in stock awards, accounting for 97% of the total pay in 2020.
Yancopoulos also received $3M in non-equity incentive plan, $1.3M in salary and $120.8K in other compensation.
Rankings
In 2020, George D. Yancopoulos' compensation ranked 17th out of 13,090 executives tracked by ExecPay. In other words, Yancopoulos earned more than 99.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 17 | 100th |
Manufacturing | 4 | 100th |
Chemicals And Allied Products | 3 | 100th |
Drugs | 3 | 100th |
Pharmaceutical Preparations | 2 | 100th |
Yancopoulos' colleagues
We found four more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2020.
2020
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2020
Andrew Murphy
Regeneron Pharmaceuticals
Executive Vice President, Research
2020
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
2020
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
News
April 21, 2022
April 23, 2021
April 24, 2020
April 26, 2019